section name header

General Information

Class Name(s):

Pronunciation:

Brand Name(s):

IMPORTANT WARNING:

Studies have shown that older adults with dementia (a brain disorder that affects the ability to remember, think clearly, communicate, and perform daily activities and that may cause changes in mood and personality) who take or receive antipsychotics (medications for mental illness) such as aripiprazole have an increased chance of death during treatment. Older adults with dementia may also have a greater chance of having a stroke or ministroke during treatment with antipsychotics.

Aripiprazole extended-release (long-acting) injection is not approved by the Food and Drug Administration (FDA) for the treatment of behavior disorders in older adults with dementia. Talk to the doctor who prescribed this medication if you, a family member, or someone you care for has dementia and is receiving aripiprazole. For more information visit the FDA website: http://www.fda.gov/Drugs.

Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with aripiprazole extended-release injection and each time you receive an injection. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) or the manufacturer's website to obtain the Medication Guide.

Talk to your doctor about the risks of receiving aripiprazole extended-release injection.

Use

WHY is this medicine prescribed?

Aripiprazole extended-release injection (Abilify Asimtufii, Abilify Maintena, Aristada, Aristada Initio) is used alone or in combination with other aripiprazole preparations to treat schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Aripiprazole extended-release injection (Abilify Asimtufii, Abilify Maintena) is also used for the ongoing treatment of people with bipolar I disorder (manic-depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). Aripiprazole is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.

HOW should this medicine be used?

Aripiprazole extended-release injection come as a powder to be mixed with water (Abilify Maintena) and as a suspension (liquid) (Abilify Asimtufii, Aristada, Aristada Initio) to be injected into a muscle by a healthcare provider.

Aripiprazole extended-release injection (Abilify Maintena) is usually given once every 4 weeks. Aripiprazole extended-release injection (Abilify Asimtufii) is usually given once every 8 weeks. If you have never received aripiprazole previously, your doctor will tell you to take aripiprazole tablets by mouth for up to 2 weeks before you receive your first injection. You will also need to take aripiprazole tablets or another antipsychotic medication by mouth for the first two weeks right after receiving your first injection of aripiprazole extended-release injection (Abilify Asimtufii, Abilify Maintena).

Aripiprazole extended-release injection (Aristada) is usually given once every 4, 6 or 8 weeks. If you have never received aripiprazole previously, your doctor will tell you to take aripiprazole tablets by mouth for up to 2 weeks before you receive your first injection. You will also need to take aripiprazole tablets by mouth for the first three weeks right after receiving your first injection of aripiprazole extended-release injection (Aristada). Alternatively, you could receive a one-time doses of aripiprazole extended-release injection (Aristada Initio) and one aripiprazole tablet by mouth when starting treatment with aripiprazole extended-release injection (Aristada).

Aripiprazole extended-release injection may help control your symptoms but will not cure your condition. Continue to keep appointments to receive aripiprazole extended-release injection even if you feel well. Talk to your doctor if you do not feel like you are getting better during your treatment with aripiprazole extended-release injection.

Are there OTHER USES for this medication?

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Special

What SPECIAL PRECAUTIONS should I follow?

Before receiving aripiprazole extended-release injection,

What SPECIAL DIETARY instructions should I follow?

Unless your doctor tells you otherwise, continue your normal diet.

What should I do IF I FORGET to take a dose?

If you forget to keep an appointment to receive aripiprazole extended-release injection (Abilify Asimtufii, Abilify Maintena, Aristrada), call your doctor to schedule another appointment as soon as possible.

Side Effects

What SIDE EFFECTS can this medicine cause?

Aripiprazole extended-release injection may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

Some side effects can be serious. If you experience any of these symptoms or those listed in the IMPORTANT WARNING or SPECIAL PRECAUTIONS sections, call your doctor immediately or get emergency medical treatment:

Aripiprazole extended-release injection may cause other side effects. Call your doctor if you have any unusual problems while you are receiving this medication.

If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Overdose

What should I do in case of OVERDOSE?

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at http://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include the following:

Miscellaneous

What OTHER INFORMATION should I know?

Keep all appointments with your doctor and the laboratory. Your doctor may order certain lab tests to check your body's response to aripiprazole extended-release injection.

Ask your pharmacist any questions you have about aripiprazole extended-release injection.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

¶ This branded product is no longer on the market. Generic alternatives may be available.

This report on medications is for your information only, and is not considered individual patient advice. Because of the changing nature of drug information, please consult your physician or pharmacist about specific clinical use.

The American Society of Health-System Pharmacists, Inc. represents that the information provided hereunder was formulated with a reasonable standard of care, and in conformity with professional standards in the field. The American Society of Health-System Pharmacists, Inc. makes no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information and specifically disclaims all such warranties. Users are advised that decisions regarding drug therapy are complex medical decisions requiring the independent, informed decision of an appropriate health care professional, and the information is provided for informational purposes only. The entire monograph for a drug should be reviewed for a thorough understanding of the drug's actions, uses and side effects. The American Society of Health-System Pharmacists, Inc. does not endorse or recommend the use of any drug. The information is not a substitute for medical care.

AHFS® Patient Medication Information Copyright, 2024. The American Society of Health-System Pharmacists®, 4500 East-West Highway, Suite 900, Bethesda, Maryland. All Rights Reserved. Duplication for commercial use must be authorized by ASHP.

Selected Revisions: June 15, 2023.